from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3428c/-

LFCtreatmentdescriptionclass of inhibitor

0.106

Amikacinug/mL Amikacintranslation

1.237

Cap5-10ug/mL Capreomycintranslation

0.766

Rox10-50 ug/mL Roxithromycintranslation

-0.345

SM2-5 ug/mL Streptomycintranslation

-0.127

Tet5-10 ug/mL Tetracyclinetranslation

0.115

Rif0.2-5ug/mL Rifampicintranscription

-0.271

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.577

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.296

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.091

CPZ10-50 ug/mL Chlorpromazinerespiration

0.634

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.743

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.161

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.075

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.344

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.475

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.006

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.233

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.635

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.466

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.449

Nigericin50 uM Nigericinrespiration

-0.668

TRC10-150 ug/mL Triclosanrespiration

0.920

TRZ10-25 ug/mL Thioridazinerespiration

2.496

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.929

menadione6-10 ug/mL Menadionerespiration

0.014

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.122

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.164

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.639

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.992

NRP_1Non-replicating persistence stage 1dosRassociated

-0.363

Amp0.2mg/mL AmpicillincellWall

0.214

Cephalexin20-100 ug/mL CephalexincellWall

-0.416

Cerulenin0.32-5 ug/mL CerulenincellWall

0.345

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.317

EMB10-20 ug/mL EthambutolcellWall

-0.567

Eta12-40 ug/mL EthionamidecellWall

-0.422

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.514

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.214

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.166

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.199

BZA0.12 mg/mL BenzamidearomaticAmides

0.541

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.028

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.371

H2O24 mM hydrogen peroxideDNAdamaging

-0.066

Levo10 ug/mL LevofloxacinDNAdamaging

-0.283

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.175

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.053

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.033

UVUV-irradiationDNAdamaging

-0.028

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.287

Antimycin12.5-50 ug/mL Antimycin A?

-0.094

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.858

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.265

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.387

PA8240.2-2 ug/mL PA-824?

-0.454

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.090

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.594

Verapamil50 uM Verapamil?

-0.509

mercaptoethanol2 mM 2-Mercaptoethanol?

0.084

methoxatin10-20 ug/mL Methoxatin?